Aberdeen Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Buy |
829,365
+38,767
| +5% | +$650K | 0.02% | 519 |
|
|
2025
Q1 | $12.2M | Buy |
790,598
+286,206
| +57% | +$4.4M | 0.02% | 517 |
|
|
2024
Q4 | $11.3M | Sell |
504,392
-88,801
| -15% | -$1.98M | 0.02% | 484 |
|
|
2024
Q3 | $10.7M | Sell |
593,193
-87,512
| -13% | -$1.58M | 0.02% | 510 |
|
|
2024
Q2 | $11.1M | Buy |
680,705
+81,998
| +14% | +$1.33M | 0.02% | 492 |
|
|
2024
Q1 | $8.45M | Buy |
598,707
+86,721
| +17% | +$1.22M | 0.02% | 579 |
|
|
2023
Q4 | $5.35M | Buy |
511,986
+449,053
| +714% | +$4.69M | 0.01% | 657 |
|
|
2023
Q3 | $642K | Sell |
62,933
-912
| -1% | -$9.3K | ﹤0.01% | 795 |
|
|
2023
Q2 | $481K | Sell |
63,845
-3,645
| -5% | -$27.4K | ﹤0.01% | 847 |
|
|
2023
Q1 | $597K | Buy |
67,490
+8,189
| +14% | +$72.5K | ﹤0.01% | 826 |
|
|
2022
Q4 | $541K | Sell |
59,301
-6,205
| -9% | -$56.6K | ﹤0.01% | 833 |
|
|
2022
Q3 | $529K | Sell |
65,506
-19,524
| -23% | -$158K | ﹤0.01% | 835 |
|
|
2022
Q2 | $676K | Sell |
85,030
-19,233
| -18% | -$153K | ﹤0.01% | 831 |
|
|
2022
Q1 | $978K | Buy |
104,263
+16,493
| +19% | +$155K | ﹤0.01% | 827 |
|
|
2021
Q4 | $703K | Sell |
87,770
-11,620
| -12% | -$93.1K | ﹤0.01% | 926 |
|
|
2021
Q3 | $991K | Buy |
99,390
+9,214
| +10% | +$91.9K | ﹤0.01% | 886 |
|
|
2021
Q2 | $893K | Buy |
90,176
+6,430
| +8% | +$63.7K | ﹤0.01% | 890 |
|
|
2021
Q1 | $967K | Sell |
83,746
-9,433
| -10% | -$109K | ﹤0.01% | 865 |
|
|
2020
Q4 | $900K | Sell |
93,179
-68,774
| -42% | -$664K | ﹤0.01% | 840 |
|
|
2020
Q3 | $1.46M | Sell |
161,953
-6,814
| -4% | -$61.4K | ﹤0.01% | 748 |
|
|
2020
Q2 | $2.08M | Buy |
168,767
+15,921
| +10% | +$196K | 0.01% | 695 |
|
|
2020
Q1 | $1.37M | Sell |
152,846
-17,861
| -10% | -$160K | ﹤0.01% | 728 |
|
|
2019
Q4 | $1.67M | Sell |
170,707
-95,078
| -36% | -$932K | ﹤0.01% | 745 |
|
|
2019
Q3 | $1.83M | Sell |
265,785
-42,307
| -14% | -$291K | ﹤0.01% | 723 |
|
|
2019
Q2 | $2.84M | Buy |
308,092
+63,800
| +26% | +$589K | 0.01% | 696 |
|
|
2019
Q1 | $3.83M | Buy |
244,292
+199,300
| +443% | +$3.13M | 0.01% | 665 |
|
|
2018
Q4 | $704K | Sell |
44,992
-30,400
| -40% | -$476K | ﹤0.01% | 793 |
|
|
2018
Q3 | $1.62M | Buy |
75,392
+6,292
| +9% | +$136K | ﹤0.01% | 751 |
|
|
2018
Q2 | $1.68M | Sell |
69,100
-13,900
| -17% | -$338K | ﹤0.01% | 747 |
|
|
2018
Q1 | $1.42M | Hold |
83,000
| – | – | ﹤0.01% | 712 |
|
|
2017
Q4 | $1.57M | Hold |
83,000
| – | – | ﹤0.01% | 702 |
|
|
2017
Q3 | $1.46M | Buy |
+83,000
| New | +$1.46M | ﹤0.01% | 694 |
|